108 related articles for article (PubMed ID: 17585752)
1. Imidazolylmethylbenzophenones as highly potent aromatase inhibitors.
Gobbi S; Cavalli A; Negri M; Schewe KE; Belluti F; Piazzi L; Hartmann RW; Recanatini M; Bisi A
J Med Chem; 2007 Jul; 50(15):3420-2. PubMed ID: 17585752
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase.
Stefanachi A; Favia AD; Nicolotti O; Leonetti F; Pisani L; Catto M; Zimmer C; Hartmann RW; Carotti A
J Med Chem; 2011 Mar; 54(6):1613-25. PubMed ID: 21341743
[TBL] [Abstract][Full Text] [Related]
3. Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation.
Gobbi S; Zimmer C; Belluti F; Rampa A; Hartmann RW; Recanatini M; Bisi A
J Med Chem; 2010 Jul; 53(14):5347-51. PubMed ID: 20568782
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cytochromes P450 with xanthone-based molecules: from aromatase to aldosterone synthase and steroid 11β-hydroxylase inhibition.
Gobbi S; Hu Q; Negri M; Zimmer C; Belluti F; Rampa A; Hartmann RW; Bisi A
J Med Chem; 2013 Feb; 56(4):1723-9. PubMed ID: 23363058
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of imidazolylmethylenetetrahydronaphthalenes and imidazolylmethyleneindanes: potent inhibitors of aldosterone synthase.
Ulmschneider S; Müller-Vieira U; Mitrenga M; Hartmann RW; Oberwinkler-Marchais S; Klein CD; Bureik M; Bernhardt R; Antes I; Lengauer T
J Med Chem; 2005 Mar; 48(6):1796-805. PubMed ID: 15771425
[TBL] [Abstract][Full Text] [Related]
6. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.
Recanatini M; Bisi A; Cavalli A; Belluti F; Gobbi S; Rampa A; Valenti P; Palzer M; Palusczak A; Hartmann RW
J Med Chem; 2001 Mar; 44(5):672-80. PubMed ID: 11262078
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
[TBL] [Abstract][Full Text] [Related]
8. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 3-(azolylmethyl)-1H-indoles and 3-(alpha-azolylbenzyl)-1H-indoles as selective aromatase inhibitors.
Le Borgne M; Marchand P; Nourrisson MR; Loquet D; Palzer M; Le Baut G; Hartmann RW
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):667-76. PubMed ID: 18035835
[TBL] [Abstract][Full Text] [Related]
10. Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
J Med Chem; 2009 Jan; 52(1):143-50. PubMed ID: 19072235
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors.
Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ
Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990
[TBL] [Abstract][Full Text] [Related]
12. Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.
Yahiaoui S; Pouget C; Buxeraud J; Chulia AJ; Fagnère C
Eur J Med Chem; 2011 Jun; 46(6):2541-5. PubMed ID: 21497425
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of benzoxazolinonic imidazoles and derivatives as non-steroidal aromatase inhibitors.
Nativelle-Serpentini C; Moslemi S; Yous S; Park CH; Lesieur D; Sourdaine P; Séralini GE
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):119-27. PubMed ID: 15449726
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors.
Lézé MP; Palusczak A; Hartmann RW; Le Borgne M
Bioorg Med Chem Lett; 2008 Aug; 18(16):4713-5. PubMed ID: 18640836
[TBL] [Abstract][Full Text] [Related]
16. New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
Yahiaoui S; Fagnere C; Pouget C; Buxeraud J; Chulia AJ
Bioorg Med Chem; 2008 Feb; 16(3):1474-80. PubMed ID: 18042388
[TBL] [Abstract][Full Text] [Related]
17. Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer.
Hu Q; Jagusch C; Hille UE; Haupenthal J; Hartmann RW
J Med Chem; 2010 Aug; 53(15):5749-58. PubMed ID: 20684610
[TBL] [Abstract][Full Text] [Related]
18. Selective dual inhibitors of CYP19 and CYP11B2: targeting cardiovascular diseases hiding in the shadow of breast cancer.
Hu Q; Yin L; Hartmann RW
J Med Chem; 2012 Aug; 55(16):7080-9. PubMed ID: 22861193
[TBL] [Abstract][Full Text] [Related]
19. CYP 17 and CYP 19 inhibitors. Evaluation of fluorine effects on the inhibiting activity of regioselectively fluorinated 1-(Naphthalen-2-ylmethyl)imidazoles.
Hartmann RW; Palusczak A; Lacan F; Ricci G; Ruzziconi R
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):145-55. PubMed ID: 15449729
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of aromatase (P450Arom) by some 1-(benzofuran-2-ylmethyl)imidazoles.
Owen CP; Nicholls PJ; Smith HJ; Whomsley R
J Pharm Pharmacol; 1999 Apr; 51(4):427-33. PubMed ID: 10385215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
